Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: May 12, 2025, 4:00 PM
1.340
0.00 (0.00%)
After-hours: May 12, 2025, 7:20 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $171.28 million as of May 12, 2025. Its market cap has decreased by -68.39% in one year.
Market Cap
171.28M
Enterprise Value
148.18M
1-Year Change
-68.39%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $171.28M, a decrease of -89.48%. That is a compound annual growth rate of -58.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 166.17M | -55.40% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |